FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and deals with method by means of which inflammation resulting from response to skin wound is reduced by introduction of sufficient quantity of inhibitor PKCα n- myristoylated peptide and insulin to requiring it subject.
EFFECT: invention ensures considerable reduction of frequency of severe wound inflammation development.
1 cl, 27 ex, 43 dwg, 5 tbl
